← Back to Search

CHIMES Intervention for Human Immunodeficiency Virus Infection (CHIMES Trial)

N/A

Waitlist Available

Led By Sophia Hussen, MD, MPH

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (months 1-12) up to month 33

Awards & highlights

CHIMES Trial Summary

This trial will test an intervention to improve YB-GBMSM's engagement in HIV and mental health care at Ryan White clinics.

Who is the study for?

This trial is for young Black gay, bisexual, and other men who have sex with men (YB-GBMSM) living with HIV. Participants must be patients at Grady Health System Infectious Disease Program or Emory University Hospital Midtown Infectious Disease Clinic.Check my eligibility

What is being tested?

The study is testing a new support intervention called CHIMES against the standard care provided in clinics. The goal is to improve how these young men engage with their HIV and mental health treatments.See study design

What are the potential side effects?

Since this trial focuses on a support intervention rather than medication, traditional side effects are not applicable. However, participants may experience emotional or psychological responses to the intervention.

CHIMES Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (months 1-12) up to month 33

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (months 1-12) up to month 33

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (months 1-12) up to month 33 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Mental Health Care Referrals

Number of Mental Health Visits

Number of Patients Attending Two HIV Care Visits

+3 more

CHIMES Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Clinic Patients During the Maintenance PeriodExperimental Treatment1 Intervention

Patients visiting one of the study clinics during the Maintenance period of the CHIMES intervention. Data will be abstracted from medical records of visits that occur during study Months 28 - 33.

Group II: Clinic Patients During the Implementation PeriodExperimental Treatment1 Intervention

Patients visiting one of the study clinics during the Implementation period of the CHIMES intervention. Data will be abstracted from medical records of visits that occur during study Months 13 - 27.

Group III: Clinic Patients During the Pre-implementation PeriodActive Control1 Intervention

Patients visiting one of the study clinics prior to implementation of the CHIMES intervention. The Baseline time period consists of study Months 1 - 12. Data are retroactively abstracted from medical records of patients who had clinic visits that occurred between January 1, 2019 and December 31, 2019.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH

2,782 Previous Clinical Trials

2,688,257 Total Patients Enrolled

Emory UniversityLead Sponsor

1,636 Previous Clinical Trials

2,559,723 Total Patients Enrolled

Sophia Hussen, MD, MPHPrincipal InvestigatorEmory University

Media Library

Standard of Care Clinical Trial Eligibility Overview. Trial Name: NCT04833829 — N/A

Human Immunodeficiency Virus Infection Research Study Groups: Clinic Patients During the Maintenance Period, Clinic Patients During the Implementation Period, Clinic Patients During the Pre-implementation Period

Human Immunodeficiency Virus Infection Clinical Trial 2023: Standard of Care Highlights & Side Effects. Trial Name: NCT04833829 — N/A

Standard of Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04833829 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the eligibility criteria for this experiment encompass individuals aged 35 or older?

"To be eligible for this medical trial, participants must fall into the age range of 18 to 29."

Answered by AI

Might I be qualified to partake in this experiment?

"For eligibility in this clinical trial, the requisite criteria are HIV infection and an age between 18-29. A total of 850 participants will be accepted for participation."

Answered by AI

Are applicants being accepted for participation in this trial at present?

"According to clinicaltrials.gov, this research project is not currently enrolling participants. It was originally made available on November 1st 2020 and most recently edited on June 7th 2022. Despite the fact that this trial isn't recruiting at present, there are 637 other studies requiring patients immediately."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Cross-disciplinary HIV Integrated Mental Health Support Intervention

Sophia Hussen 2020. "Cross-disciplinary HIV Integrated Mental Health Support Intervention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04833829.

All > Mens Health > Aids